2010
DOI: 10.1556/oh.2010.28956
|View full text |Cite
|
Sign up to set email alerts
|

Surgical treatment of acute pancreatitis today

Abstract: sterile pancreas necrosis is rarely but septic necrosis is an indication for surgery if the conservative treatment is unsuccessful. Therapy resistant multiple organ failure, abdominal compartment syndrome and other surgical complications such as bleeding, perforation need surgery treatment. In biliary pancreatitis associated with cholestasis urgent endoscopic sphincterotomy and later cholecystectomy is suggested. In case of pancreas necrosis the ideal time of operation is 21 days after the beginning of the dis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 38 publications
0
1
0
Order By: Relevance
“…After the advance understanding of the path physiology of SAP, the treatment mode has changed over the past few years. The early and aggressive management of SAP has been used extensively, such as TNF-alpha monoclonal antibodies, IL receptor antagonist, PAF antagonist [ 30 ], persistence of surgery [ 31 ], peritoneal lavage [ 32 ], dialysis [ 19 ], continuous arterial infusion of protease inhibitor [ 33 , 34 ], and endothelin receptor antagonist to reduce capillary leakage [ 35 ], in addition to intensive care. During SAP, both pro- and anti-inflammatory mediators become unregulated and interact with each other, leading to cascades of chain reactions, so neither antagonist treatment directed at one mediator nor the single dose intervention was effective.…”
Section: Discussionmentioning
confidence: 99%
“…After the advance understanding of the path physiology of SAP, the treatment mode has changed over the past few years. The early and aggressive management of SAP has been used extensively, such as TNF-alpha monoclonal antibodies, IL receptor antagonist, PAF antagonist [ 30 ], persistence of surgery [ 31 ], peritoneal lavage [ 32 ], dialysis [ 19 ], continuous arterial infusion of protease inhibitor [ 33 , 34 ], and endothelin receptor antagonist to reduce capillary leakage [ 35 ], in addition to intensive care. During SAP, both pro- and anti-inflammatory mediators become unregulated and interact with each other, leading to cascades of chain reactions, so neither antagonist treatment directed at one mediator nor the single dose intervention was effective.…”
Section: Discussionmentioning
confidence: 99%